Business● Low1h ago · Nov 4, 2026, 1:06 PM
UroGen Pharma GAAP EPS of -$0.03 misses by $0.13, revenue of $89M misses by $0.91M
GlobeAlert Desk · curated from Seeking Alpha Tech · North America
UroGen Pharma's GAAP EPS of -$0.03 missed estimates by $0.13, and its revenue of $89M missed by $0.91M. This indicates a financial performance below analyst expectations for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
North America theater · last 7 days
rising · 26 in the last 24h962
events logged
96
risk index / 100
Attacks & Assaults 420Shootings 218Robberies & Theft 184Floods 45Rocket Launches 36
- Cyber activity (100 reports)Cyber Threats · · 15m ago
- Protest activity (121 reports)Protests · · 17m ago
- Conflict activity (153 reports)Conflict Events · · 17m ago